Hypoglycaemic effects of fermented mycelium of Paecilomyces farinosus (G30801) on high-fat fed rats with streptozotocin-induced diabetes

Indian Journal of Medical Research

Volumn 131, Issue 5, 2010, Pages 696-701

  Lu, Huai En ^a   Jian, Chien Huei ^a   Chen, Shu Fen ^a   Chen, Tse Min ^b   Lee, Son Tay ^c   Chang, Chun Sheng ^c   Weng, Hing Feng ^a  

^a NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Diabetes; High fat; Hypoglycaemia; Insulin; Paecilomyces farinosus; Streptozotocin

Indexed keywords

CHOLESTEROL; GENE PRODUCT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PAECILOMYCES FARINOSUS EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FERMENTATION; FUNGAL STRAIN; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MYCELIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAECILOMYCES; PAECILOMYCES FARINOSUS; RAT; RICE; SOYBEAN; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; FERMENTATION; GLUCOSE TOLERANCE TEST; PAECILOMYCES; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 77952372043     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24: 1936-40.
2. Ruchat SM, Elks CE, Loos RJ, Vohl MC, Weisnagel SJ, Rankinen T, et al. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies. Acta Diabetol 2009; 46: 217-26.
3. Emerson P, Van Haeften TW, Pimenta W, Plummer E, Woerle HJ, Mitrakou A, et al. Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus. Metabolism 2009; 58: 602-7.
4. Gong W, Lu B, Yang Z, Ye W, Du Y, Wang M, et al. Early- stage atherosclerosis in newly diagnosed, untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Metab 2009; 35: 458-62.
5. Haffner SM. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 2002; 90: 55i-61i.
6. Gloyn AL. The search for type 2 diabetes genes. Ageing Res Rev 2003; 2: 111-27.
7. Kesari AN, Kesari S, Singh SK, Gupta RK, Watal G. Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals. J Ethnopharmacol 2007; 112: 305-11.
8. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomed 1995; 2: 137-89.
9. de Melo Júnior EJ, Raposo MJ, Lisboa Neto JA, Diniz MF, Marcelino Júnior CA, Sant'Ana AE. Medicinal plants in the healing of dry socket in rats: microbiological and microscopical analysis. Phytomedicine 2002; 9: 109-16.
10. Cheng Y, Schneider B, Riese U, Schubert B, Li Z, Hamburger M. Neurotrophic alkaloidal metabolites from the entomogenous deuteromycete Paecilomyces farinosus. J Nat Prod 2005; 67: 1854-8.
11. Lang G, Blunt JW, Cummings NJ, Cole AL, Munro MH. Paecilosetin, a new bioactive fungal metabolite from a New Zealand isolate of Paecilomyces farinosus. J Nat Prod 2005; 68: 810-1.
12. Jiang YH, Jiang XL, Wang P, Hu XK. In vitro antioxidant activities of water-soluble polysaccharides extracted from Isaria farinosa B05. J Food Biochem 2005; 29: 323-35.
13. Jiang YH, Jiang XL, Wang P, Mou HJ, Hu XK, Liu SQ. The antitumor and antioxidative activities of polysaccharides isolated from Isaria farinosa B05. Microbiol Res 2008; 163: 424-30.
14. Staub AM. Removal of protein - Sevag method. Methods Carbohyd Chem 1965; 5: 5-6.
15. Xiao JH, Chen DX, Xiao Y, Liu JW, Liu ZL, Wan WH, et al. Optimization of submerged culture conditions for mycelia polysaccharide production in Cordyceps pruinosa. Process Biochem 2004; 39: 2241-7.
16. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-6.
17. Eddouks M, Maghrani M, Michel JB. Hypoglycaemic effect of Triticum repens P. Beauv. in normal and diabetic rats. J Ethnopharmacol 2005; 102: 228-32.
18. Kamgang R, Mboumi RY, N'dillé GP, Yonkeu JN. Cameroon local diet-induced glucose intolerance and dyslipidemia in adult Wistar rat. Diabetes Res Clin Pract 2005; 69: 224-30.
19. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, et al. The rat model of type 2 diabetic mellitus and its glycometabolism characters. J Exp Sci Anim 2003; 52: 401-7.
20. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008; 2008: 7040-5.
21. Islam MS, Loots DT. Experimental rodent models of type 2 diabetes: A review. Methods Find Exp Clin Pharmacol 2009; 31: 249-61.
22. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Revs 1994; 15: 516-42.
23. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 1969; 48: 2129-39.
24. Fisher J. Drugs and chemicals that produce diabetes. Trends Pharmacol Sci 1985; 6: 72-5.
25. Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S, et al. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: A new rat model of diabetic nephropathy. Nutr Metab Cardiovasc Dis 2006; 16: 477-84.
26. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 2005; 68: 2562-71.
27. Taskinen MR. Lipoprotein and apoproteins in diabetes. In: Belfiore F, Bergnan RN, Molinatt GM, editors. Current topics in diabetes research, vol 12. Informa Health Care. 1996. p. 122-34.
28. Temme EH, Van HPG, Schouten EG, Kesteloot H. Effect of a plant sterol-enriched spread on serum lipids and lipoprotein in mildly hypercholesterolaemic subjects. Acta Cardiol 2002; 57: 111-5.
29. Baynes JW. Role of oxidative stress in the development of complications in diabetes. Diabetes 1991; 40: 405-12.
30. Yolanda BL, Adriana GC. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. J Nutr Biochem 2006; 17: 1-13.
31. Kiho T, Ookubo K, Usui S, Ukai S, Hirano K. Structural features and hypoglycemic activity of a polysaccharide (CS- F10) from the cultured mycelium of Cordyceps sinensis. Biol Pharm Bull 1999; 22: 966-70.